P4‐323: VALIDATION OF THE CHINESE VERSION OF RELEVANT OUTCOME SCALE FOR ALZHEIMER'S DISEASE (ROSA)

Qihao Guo

DOI: https://doi.org/10.1016/j.jalz.2014.07.094

2014-01-01

Alzheimer s & Dementia

Abstract:The Relevant Outcome Scale for Alzheimer's disease (ROSA) is a novel observer rating scale developed for daily clinical practice, with characteristics of easy and quick administration, multi-domain assessment, relevance for all AD severity stages, and suitability for long-term monitoring disease progression etc. This study was to verify the validity of the Chinese version of ROSA. The original English version of ROSA included 16 items was translated into Chinese and back-translated to verify by the study group. A total of 332 outpatients diagnosed with probable AD according to the criteria of NIA-AA guideline were recruited and assessed with ROSA and other standard Chinese rating scales which frequently used for the assessments of AD. Construct and concurrent validities of the Chinese version of ROSA were measured. Correlations of the total score of ROSA with scores of single item, subscales, and the other assessments were analyzed by Pearson correlation test or Spearman correlation analysis. The scores of each single item were significantly correlated with the total score of ROSA (r-value range, 0.363-0.817, P < 0.01). The scores of six dimensions of ROSA, i.e., cognition (item 1-3), communication (item 4-6), behavior (item 7-11), function (item12-14), quality of life (item 15) and caregiver burden (item 16) were highly correlated with the total score of ROSA (r-value range, 0.638∼0.855, P < 0.01). The score of ROSA was significantly correlated with the scores of Mini Mental State Examination, Mattis Dementia Rating Scale, and Disability Assessment for Dementia (r=0.441, 0.575, 0.346 respectively, P < 0.01), and significantly negatively correlated with the scores of Alzheimer's Disease Assessment Scale-cognitive, The Informant Questionnaire on Cognitive Decline in the Elderly, Neuropsychiatric Inventory, and Zarit Caregiver Burden Interview ((r=-0.576, -0.540, -0.472, -0.346 respectively, P < 0.01). The Chinese version of ROSA is a valid and easy-administrative instrument to assess Chinese patients with AD and worth to be applied in the clinical practice and clinical studies.